Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Sana Biotechnology, Inc. (SANA) had Income from Continuous Operations of $-93.80M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-93.80M |
|
-- |
|
-- |
|
$94.97M |
|
$-94.97M |
|
$1.18M |
|
$-93.80M |
|
$-93.80M |
|
$-93.80M |
|
|
Income from Continuous Operations |
$-93.80M |
$-93.80M |
|
$-93.80M |
|
$-94.97M |
|
$-92.12M |
|
238.41M |
|
238.41M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$82.50M |
|
$33.08M |
|
$279.14M |
|
$361.64M |
|
$33.44M |
|
-- |
|
$205.65M |
|
$239.09M |
|
$122.56M |
|
$-77.27M |
|
$122.56M |
|
230.51M |
|
| Cash Flow Statement Financials | |
$-81.76M |
|
$24.28M |
|
$1.54M |
|
$131.40M |
|
$75.47M |
|
$-55.93M |
|
$13.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-76.54% |
|
121.40% |
|
-25.94% |
|
-76.54% |
|
$0.53 |
|
$-0.34 |
|
$-0.34 |
|